Who Paid My Doc
Latera
Device Spirox
PDI 00857037006037
General payments
$2,571,491
Research payments
$2,470
Through program year 2025, $2,571,491 in general payments and $2,470 in research payments were reported against Latera (Spirox).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $517,256 | 227 |
| 2024 | General | $258,585 | 232 |
| 2023 | General | $318,326 | 325 |
| 2022 | General | $965,444 | 1,426 |
| 2021 | General | $511,879 | 952 |
| 2021 | Research | $2,470 | 8 |
Breakdown
The top 5 of 91 recipients; each share is of general payments naming this product in 2025.
The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 21 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
3,162 general · 8 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.